Outcomes of a Pharmacy-Driven Inpatient Chronic Obstructive Pulmonary Disease (COPD) Transitions of Care (TOC) Management Process

被引:1
|
作者
Roberts, Aaron [1 ,4 ]
Ball, Meredith Hope [2 ]
Bentley, Austin Clark [1 ]
Rafferty, Aubrie [3 ]
机构
[1] UNC Chapel Hill Eshelman Sch Pharm, Chapel Hill, NC USA
[2] WakeMed Hlth & Hosp, Dept Pharm, Raleigh, NC USA
[3] Mission Hosp, Dept Pharm, Mission Campus, Asheville, NC USA
[4] Univ North Carolina Chapel Hill, Eshelman Sch Pharm, 301 Pharm Ln, Chapel Hill, NC 27599 USA
关键词
transitions of care; COPD; layered learning; READMISSIONS;
D O I
10.1177/08971900231168927
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Current data shows 30% of patients hospitalized for Chronic Obstructive Pulmonary Disease (COPD) exacerbation are readmitted within 30 days. Medication management during transitions of care (TOC) has shown impact on clinical outcomes, however there is insufficient data to suggest how pharmacy TOC services might benefit this patient population. Objective Evaluate the effects of pharmacy-driven COPD TOC services on hospital re-presentation rates. Methods A single-center retrospective chart review conducted of patients hospitalized for a COPD exacerbation. A comprehensive admission-to-discharge TOC service was provided by early immersion pharmacy students, advanced immersion pharmacy students, and an attending pharmacist in a layered learning model. The primary outcome was 30-day re-presentation rate. Secondary outcomes were 90-day re-presentation rate, volume of interventions made and description of the service. Results From 1/1/2019 to 12/31/2019, there were 2422 patients admitted for COPD exacerbation management and 756 patients received at least one intervention from the COPD TOC service. 30% needed a change to inhaler therapy. The provider accepted 57.8% of the recommended changes, and 36% and 33% of eligible patients received an inhaler technique education and bedside delivery of the new inhaler, respectively. Outcomes in the 30-day re-presentation and 90-day censored re-presentation rates for the intervention and control group were 28.5% vs 25.5% (P = .12) and 46.7% vs 42.9%, respectively. Conclusion This study did not find a significant change in 30-day re-presentation rate with a pharmacy-driven COPD TOC service. It did find that a significant number of patients admitted with COPD exacerbation may need an inhaler change, and demonstrates the utility of this kind of TOC service for identifying and correcting medication-related problems unique to this disease state. There were opportunities for improvement in percent of patients receiving the full intended intervention.
引用
收藏
页码:677 / 682
页数:6
相关论文
共 50 条
  • [21] Contribution of Anxiety and Depression on Chronic Obstructive Pulmonary Disease (COPD) Outcomes
    O'Toole, J.
    Putcha, N.
    Cooper, C. B.
    Woodruff, P.
    Kanner, R. E.
    Paine, R.
    Bowler, R. P.
    Comellas, A. P.
    Krishnan, J. A.
    Han, M. K.
    Dransfield, M. T.
    Iyer, A. S.
    Couper, D.
    Peters, S. P.
    Criner, G. J.
    Barr, R. G.
    Martinez, F. J.
    Hansel, N. N.
    Eakin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [22] Impact of Memory Impairments on Chronic Obstructive Pulmonary Disease (COPD) Outcomes
    O'Toole, J.
    Eckmann, T.
    Eakin, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] VENTILATOR USE IN THE INPATIENT MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    BELMAN, MJ
    BARATZ, DM
    WESTERN JOURNAL OF MEDICINE, 1990, 153 (01): : 72 - 73
  • [24] Continuity of Care and Avoidable Hospitalizations for Chronic Obstructive Pulmonary Disease (COPD)
    Lin, I-Po
    Wu, Shiao-Chi
    Huang, Shu-Tzu
    JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2015, 28 (02) : 222 - 230
  • [25] Improving the process of care in chronic obstructive pulmonary disease: The COPD Assessment Test (CAT) in the armature of the tools assessing COPD
    Kaltsakas, Georgios
    Travlos, Apostolos
    Rovina, Nikoletta
    PNEUMON, 2011, 24 (03) : 286 - 291
  • [26] Personalised multidisciplinary management for patients with chronic obstructive pulmonary disease (COPD)
    Marshall, Henry M.
    Vaughan, Annalicia
    Yang, Ian A.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S2115 - S2116
  • [27] Ambulatory management of chronic obstructive pulmonary disease (COPD):: A consensus report
    Moreno, R
    González, P
    REVISTA MEDICA DE CHILE, 1999, 127 (02) : 229 - 234
  • [28] Guideline for the Management of Chronic Obstructive Pulmonary Disease (COPD): 2004 revision
    Bateman, ED
    Feldman, C
    O'Brien, J
    Plit, M
    Joubert, JR
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2004, 94 (07): : 559 - 575
  • [29] Therapeutic options in the management of stable chronic obstructive pulmonary disease (COPD)
    Schäfer, H
    Ewig, S
    Gillissen, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2000, 125 (08) : 230 - 235
  • [30] IMPACT OF FAMILY MEDICINE ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT
    Alali, Abdulaziz Yarub
    Alshahrani, Abdullah Nasser
    Asseri, Abdulwahab Ali
    Alanazi, Waleed Turki
    Albalawi, Othman Masad
    Alshaikhi, Ahmed Hussain
    Alwadai, Abdulrhman Nasser
    Makai, Ahmad Jamil
    Alali, Omar Yarub
    Aljohani, Talal Rabea Marzooq
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 2767 - 2773